Contact Us


Your Name (required)

Your Email (required)

Subject

Your Message

DSCSA Compliance

Extensive Event Participation Expands Awareness

As a vital part of any company’s growth, it is important to generate connections. The WDSrx marketing team event strategy focuses on a range of industries and supply chain groups to discuss WDSrx services with a wide variety of prospects. A concentrated event schedule generated new contacts and quality interactions with industry professionals.  WDSrx recently participated in several events such as the Health and Personal Care Logistics Conference in Chicago, Illinois; the BioFlorida annual co...

Manufacturers Rely On Logistics Services Providers For Complete Serialization

Manufacturers faced with the prospect of significant costs to meet the impending deadline for DSCSA compliance can achieve savings and peace-of-mind by outsourcing to serialization-ready third party logistics providers. Many pharmaceutical manufacturers choose not to make the significant investment to upgrade hardware, software, equipment and training for pharmaceutical serialization requirements.  In addition to realizing cost savings compared with outright equipment purchase, these programs a...

WDSrx Monthly News Update August 2017

WDSrx gets published on DC Velocity, sponsors an HDA Serialization Survey, attends NACDS this month and welcomes a new member of our business development team. Read our monthly update for details. ...

Serialization Implementation and Operations for DSCSA Compliance (updated July 2018)

SUMMARY With the stroke of a pen in 2013, the pharmaceutical industry mobilized in order to comply with sweeping changes enacted by the Drug Quality and Security Act. The law includes the Drug Supply Chain Security Act (“DSCSA”), written to increase patient safety by minimizing risk from unauthorized pharmaceutical drug products entering the marketplace.   The Food and Drug Administration, charged with enforcing the Act, set deadlines for the industry to comply with this law. The law requi...

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.